2018 WAS ANOTHER IMPORTANT YEAR FOR SOM BIOTECH with new rounds of investments, a clinical asset in the pipeline and three new products ready for proof of concept. SOM has been making excellent progress in the past months and we wanted to use this letter as a forum to share how we are leveraging our…
Executing strategies for maximizing firm value
posted on December 17, 2018
Season’s greetings from SOM
posted on December 14, 2018
Each year, the SOM Biotech team celebrates Christmas by dining out and doing some fun activities to foster camaraderie. For this year's activity, the team decided to do a "psychiatry" escape room challenge wherein motivation, leadership and teamwork were tried. It was a great team-building activity that promoted unity among the team members, and a fun way to…
Early Stage Value Creation Panel Discussion
posted on December 11, 2018
Farmantra, a Barcelona-based corporate finance advisory for life sciences companies specializing in early stage valuations, interim CFO support and fund raising, hosted a panel discussion on early stage value creation at Cal Tip Barcelona on the 29th of November. The discussion was focused on topics such as fund-raising management, early dilution through equity-raising, early licensing of assets,…
SOMCT02 Huntington’s disease trial recruits 50% of patient target
posted on November 12, 2018
On November 2, 2018, the SOMCT02 clinical trial successfully recruited its 15th patient, marking 50% fulfillment of its targeted number of patients. Recruitment rate is quite quick with all patients expected to be enrolled by the end of this year. SOM Biotech is very proud of all the efforts being done by the participating sites,…
SOM Biotech at BIO Europe 2018
posted on November 8, 2018
Europe's largest annual life science partnering conference was held on November 5-7, 2018 in Copenhagen. BIO Europe serves as a forum for companies across the biotech value chain to meet and do business through one-to-one meetings, workshops, panels and exhibitions. The three-day conference drew over 4,000 industry attendees of high level networking, representing more than 2,000 companies from…
SOM Biotech invited to “Preferències” radio show
posted on October 31, 2018
Each month, “Preferències” director and host Josep Maria Carrasco presents companies of special interest located at the PCB (Barcelona Science Park) on the RTVE Radio 4 channel. The radio show tackles all things innovative, from fashion to music, cinema to gastronomy, art to science. On September 27th, SOM Biotech CEO Dr. Raúl Insa was invited…